| Cell line name |
43-9F |
|---|
| Accession |
CVCL_UF07 |
|---|
| Resource Identification Initiative |
To cite this cell line use: 43-9F (RRID:CVCL_UF07) |
|---|
| Comments |
Group: Patented cell line.
Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 85061402.
Monoclonal antibody isotype: IgM.
Monoclonal antibody target: Beta-Gal(1->3)-[alpha-Fuc(1->4)]-beta-GlcNAc(1->3)-beta-Gal(1->4)[alpha-Fuc(1->3)]beta-GlcNAc(1->3)-R. |
|---|
| Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
|---|
| Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) |
|---|
| Category |
Hybridoma |
|---|
| Publications | Patent=EP0184906A1
Olsson L.
Monoclonal antibodies specific for human squamous lung carninoma cells, their preparation and use.
Patent number EP0184906A1, 18-Jun-1986 PubMed=2433033
Pettijohn D.E., Stranahan P.L., Due C., Ronne E., Sorensen H.R., Olsson L.
Glycoproteins distinguishing non-small cell from small cell human lung carcinoma recognized by monoclonal antibody 43-9F.
Cancer Res. 47:1161-1169(1987) PubMed=2445477
Due C., Eriksson H., Sihm A., Olsson L.
Association between expression of a tumor-associated carbohydrate epitope and the proliferative and tumorigenic activity of a human squamous lung cancer cell line and epitope-positive and -negative sublines.
Cancer Res. 47:6697-6704(1987) PubMed=3422461; DOI=10.1073/pnas.85.3.802
Pettijohn D.E., Pfenninger O., Brown J., Duke R., Olsson L.
Tumorigenic human squamous lung cancer cells have defined cell surface carbohydrates that are absent from nontumorigenic cells.
Proc. Natl. Acad. Sci. U.S.A. 85:802-806(1988) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q93306930
|
|---|
| Entry history |
|---|
| Entry creation | 13-Nov-2018 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 4 |
|---|
